Drug Database
Back to search

Ireland· IE-PA-PA2059/041/005

Intralipid 20% w/v Emulsion for Infusion Biofine bag

A fettemulsionen product containing soya bean oil, refined, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedIntralipid 20% w/v Emulsion for Infus…ATCB05BA02REGISTER NO.IE-PA-PA2059/041/005PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about soya bean oil, refinedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose
Search fettemulsionen products by name

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Soya bean oil, refined
Manufacturer
Fresenius Kabi Deutschland GmbH
Country
Ireland (IE)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2059/041/005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B05BA02

Fettemulsionen, as other registers publish it.

All fettemulsionen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5847460-0cc6-46b9-8140-d9bf1f94fe79
GET /v1/drugs/f5847460-0cc6-46b9-8140-d9bf1f94fe79?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B05BA",
    "B05BA02"
  ],
  "strength": null,
  "pa_number": "PA2059/041/005",
  "substances": [
    "Soya bean oil, refined"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "30/11/2012",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console